Provided by Tiger Trade Technology Pte. Ltd.

Danaher

211.76
-9.7900-4.42%
Post-market: 211.760.00000.00%19:58 EDT
Volume:5.30M
Turnover:1.14B
Market Cap:149.58B
PE:37.58
High:222.00
Open:221.31
Low:211.18
Close:221.55
52wk High:242.80
52wk Low:160.93
Shares:706.35M
Float Shares:640.16M
Volume Ratio:1.09
T/O Rate:0.83%
Dividend:1.44
Dividend Rate:0.68%
EPS(TTM):5.63
EPS(LYR):5.07
ROE:7.60%
ROA:3.95%
PB:2.84
PE(LYR):41.76

Loading ...

Thermo Fisher Raises Annual Profit Forecast as Customer Demand Improves

Reuters
·
Jul 23

Dover Q2 Revenue Rises, but Slightly Misses Estimates

Reuters
·
Jul 23

Thermo Fisher Q2 Revenue Beats Estimates Amid Strong Customer Activity

Reuters
·
Jul 23

Sweden's Genovis Q2 Net Sales Rise 19% on Product Growth

Reuters
·
Jul 23

France's Eurofins H1 Revenue up 2.5% on Investment in Laboratory Network

Reuters
·
Jul 23

France's Sartorius Stedim Biotech H1 Revenue Rises on Recurring Consumables

Reuters
·
Jul 23

Sweden's Mentice Q2 Sales Rise, Ebitda Turns Positive on Strategic Initiatives

Reuters
·
Jul 23

Medpace Q2 Revenue Beats Estimates on Backlog Conversion

Reuters
·
Jul 23

Danaher Posts Mixed Q2 Results, Outlook for 2027 and Beyond Strengthened, RBC Says

MT Newswires Live
·
Jul 22

Danaher is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 22

Movement Alert|Danaher Falls 3.34% in Regular Trading, Weak Q3 Growth Guidance and Institutional Price Target Cuts Extend Post-Earnings Selling

Market Focus
·
Jul 22

Danaher Unit Cepheid Unveils Third-generation Genexpert System at ADLM 2026

Reuters
·
Jul 22

Jefferies Sticks to Its Buy Rating for Danaher (DHR)

TIPRANKS
·
Jul 22

Danaher price target lowered to $236 from $240 at TD Cowen

TIPRANKS
·
Jul 22

Danaher: Analyst Reaffirms Buy, Lifts Price Target to $255 on Long-Term Bioprocessing Upside and Life Sciences Strength

TIPRANKS
·
Jul 22

Wells Fargo Remains a Hold on Danaher (DHR)

TIPRANKS
·
Jul 22

Danaher Corporation : Wells Fargo Cuts Target Price to $195 from $212

THOMSON REUTERS
·
Jul 22

Repligen Beefs up Cell Therapy Business with $1.5 Billion Deal for Biolife

Reuters
·
Jul 22

Morgan Stanley Adjusts Price Target on Danaher to $220 From $255, Maintains Overweight Rating

MT Newswires Live
·
Jul 22

Don't Quit on Danaher Stock After Horrific Earnings Reaction

Dow Jones
·
Jul 22